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Abstract. 
 
Mutations in the adenomatous polyposis coli 
(APC) tumor suppressor gene are linked to both famil-
ial and sporadic human colon cancer. So far, a clear bio-
logical function for the APC gene product has not been 
determined. We assayed the activity of APC in the 
early 
 
Xenopus
 
 embryo, which has been established as a 
good model for the analysis of the signaling activity of 
the APC-associated protein 
 
b
 
-catenin. When ex-
pressed in the future ventral side of a four-cell embryo, 
full-length APC induced a secondary dorsoanterior axis 
and the induction of the homeobox gene 
 
Siamois.
 
 This 
is similar to the phenotype previously observed for ec-
topic 
 
b
 
-catenin expression. In fact, axis induction by 
APC required the availability of cytosolic 
 
b
 
-catenin. 
These results indicate that APC has signaling activity in 
the early 
 
Xenopus
 
 embryo. Signaling activity resides in 
the central domain of the protein, a part of the mole-
cule that is missing in most of the truncating APC mu-
tations in colon cancer. Signaling by APC in 
 
Xenopus
 
 
embryos is not accompanied by detectable changes in 
expression levels of 
 
b
 
-catenin, indicating that it has di-
rect positive signaling activity in addition to its role in 
 
b
 
-catenin turnover. From these results we propose a 
model in which APC acts as part of the Wnt/
 
b
 
-catenin 
signaling pathway, either upstream of, or in conjunction 
with, 
 
b
 
-catenin.
 
T
 
he
 
 adenomatous polyposis coli (APC)
 
1
 
 gene is a tu-
mor suppressor gene linked to familial adenoma-
tous polyposis (FAP) and to the initiation of spo-
radic human colorectal cancer (9, 18, 20, 32, 40). Most
FAP patients carry one allelic APC mutation in the 5
 
9
 
 half
of the coding sequence, which usually causes chain termi-
nation and results in the expression of truncated proteins.
Colon polyps appear after the loss or mutation of the re-
maining wild-type allele, indicating that the mutant trun-
cated APC does not act in a dominant-negative fashion by
inactivating the wild type (34, 35). All mutant proteins lack
the COOH-terminal half, suggesting that some growth-
suppressing or growth-regulating activity is present in this
part of the molecule (39).
The structure of the APC protein provides many hints
about its possible cellular function. The 
 
APC
 
 gene en-
codes a 300-kD protein, consisting of 2,843 amino acids,
which has several structural domains. The NH
 
2
 
-terminal
third contains an oligomerization domain, followed by seven
armadillo repeats (imperfect repeats also found in pro-
teins like armadillo, 
 
b
 
-catenin, plakoglobin, and import-
ins). The middle part of the protein contains three succes-
sive 15–amino acid (aa) repeats, followed by seven related
but distinct 20-aa repeats. Both types of repeats are able to
bind independently to 
 
b
 
-catenin, a cadherin-associated
protein important for intercellular adhesion (42, 43, 51).
All truncated APC proteins lack most of the 20-aa repeats,
but the majority of the somatic mutant APC proteins seem
to have retained the 15-aa repeats and 
 
b
 
-catenin–binding
activity (39). The COOH-terminal third of the APC pro-
tein contains a basic region and has recently been shown
to bind the human homologue of the 
 
Drosophila
 
 disc large
(Dlg) tumor suppressor protein (23) and a novel protein
EB1 (52). In addition, the COOH terminus can bind to mi-
crotubules and promote their assembly in vitro (28, 48).
The discovery that APC interacts with 
 
b
 
-catenin leads to
the proposal that it functions as a regulator of adhesion
(14, 42, 51). 
 
b
 
-Catenin binds to cadherins and is required for
full cadherin activity. In the meantime, however, 
 
b
 
-catenin
has also been shown to have signal transduction activity.
Its homologue in 
 
Drosophila
 
, 
 
armadillo
 
, is a segment po-
larity gene that acts as a component of the Wingless signal-
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Xenopus
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 disc large; EF-1,
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gen synthase kinase 3; dNTP, deoxyribonucleotidetriphosphate; RT, re-
verse transcriptase.
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ing pathway (36). Furthermore, 
 
b
 
-catenin has been found
to be involved in axial patterning of early 
 
Xenopus
 
 em-
bryos (8, 24). The formation of the dorsoanterior axis in
 
Xenopus
 
 results from localized signaling activities in the
dorsal vegetal zone (the Nieuwkoop center) of an early
embryo. Injection of synthetic 
 
b
 
-catenin mRNA in the fu-
ture ventral side of an early embryo mimics the Nieuw-
koop center and results in the formation of a secondary
dorsal axis, manifested by the appearance of double-
headed embryos. Induction of a secondary axis by 
 
b
 
-cate-
nin is cadherin independent, and by implication indepen-
dent of cell–cell adhesion (6).
In the 
 
Xenopus
 
 embryo, 
 
b
 
-catenin seems to be part of a
Wnt signaling pathway, which was first identified as the
Wingless pathway in 
 
Drosophila
 
 (21, 36). Many compo-
nents of this signaling pathway were identified and epistat-
ically ordered using genetic screens of 
 
Drosophila
 
 mutants
that show aberrant embryonic pattern formation. These
so-called segment polarity genes include 
 
wingless
 
 (
 
wg
 
, en-
coding the 
 
Drosophila
 
 homologue of the Wnt growth fac-
tors), 
 
disheveled
 
 (
 
dsh
 
, encoding a protein with unknown
function), 
 
zeste white 3
 
/
 
shaggy
 
 (
 
zw3
 
/
 
shaggy
 
, homologue of
glycogen synthase kinase 3 [GSK-3]), 
 
armadillo
 
 (homo-
logue of 
 
b
 
-catenin), and 
 
engrailed
 
 (a transcription factor).
Wingless signaling leads to the accumulation of cytoplas-
mic armadillo through the inactivation of zeste white 3, a
kinase that promotes the turnover of cytoplasmic arma-
dillo protein. The Wg-induced increase in cytoplasmic ar-
madillo protein then results in the induction of target
genes, including 
 
engrailed.
 
 The Wingless/Wnt pathway has
been remarkably well conserved in vertebrates, as evident
in early 
 
Xenopus
 
 embryogenesis. Wnt, XDsh and 
 
b
 
-cate-
nin can all induce an ectopic dorsoanterior axis (8, 11, 33,
49, 50), while the Zeste White 3 homologue GSK-3 antag-
onizes axis formation (4, 12, 38).
Recent findings suggest that APC may also be part of
the Wnt signaling pathway. APC can physically interact
with both 
 
b
 
-catenin and GSK-3, two components of the
Wnt pathway (44). Also, APC seems to be a good sub-
strate for GSK-3 in vitro, and phosphorylation of its cen-
tral 20-aa repeat region promotes the binding of 
 
b
 
-catenin.
Earlier observations implicated this central region of APC
in the regulation of 
 
b
 
-catenin levels (29). However, it has
not yet been shown directly that APC participates in a sig-
naling pathway in vivo. Also, the significance of the effect of
 
b
 
-catenin turnover for signaling has not been determined.
We used the induction of an ectopic dorsal axis in early
 
Xenopus
 
 embryos as a model system to test whether APC
has signaling activity and whether it influences 
 
b
 
-catenin
in vivo.
 
Materials and Methods
 
cDNA Cloning and Vector Construction
 
Degenerate primers flanking the 
 
b
 
-catenin binding sites of human APC
were used to generate a PCR fragment from a 
 
Xenopus
 
 gt-10 
 
l
 
 cDNA li-
brary. About 5 
 
m
 
l of the library, which had a titer of 1.5 
 
3
 
 10
 
5
 
, was boiled
for 5 min and directly used as a PCR template in a 100-
 
m
 
l reaction consist-
ing of 1 
 
3
 
 PCR buffer containing Mg
 
2
 
1
 
 (Promega Corp., Madison, WI),
dNTPs, 100 mM each, 100 pmol of each primer, and 5 U Taq polymerase
(Boehringer Mannheim Biochemicals, Indianapolis, IN). The sense primer
corresponded to the peptide sequence NHMDDND with a 32-fold degen-
eracy. The antisense primer, corresponding to the peptide sequence
YCVEDTP, was 132-fold degenerate. Using 30 cycles of 1-min denatur-
ing, annealing, and extension steps of 94
 
8
 
, 51
 
8
 
, and 72
 
8
 
C, respectively, we
obtained a 750-bp fragment that when sequenced confirmed its homology
to the human APC cDNA. This PCR fragment was then used to screen
the 
 
Xenopus
 
 gt-10 
 
l
 
 cDNA library. We first obtained clone 6A, encom-
passing the NH
 
2
 
-terminal third (including 100 bp of untranslated region)
of the 
 
Xenopus
 
 APC cDNA and clone 3bF1 containing the middle part of
 
Xenopus
 
 APC cDNA. Using the 400 bp of the 3
 
9
 
 end of 3bF1 as a probe,
we rescreened the library and obtained clone 40.2, which encompassed
3bF1 but extended 450 bp futher to the 3
 
9
 
 end, and a clone 36.2 of 
 
z
 
3 kb,
partially overlapping with 3bF1 and 40.2 but extending 2.2 kb further to
the COOH terminus, still 150 bp short of the stop codon. A final screen of
the library with a 600-bp probe obtained from the 3
 
9
 
 end of clone 36.2 ulti-
mately generated clone 111 containing the complete COOH-terminal
third, including the stop codon and 150 bp of 3
 
9
 
 untranslated region.
The full-length 
 
Xenopus
 
 APC cDNA (XAPC FL) and cDNAs encod-
ing APC fragments (XAPC 1, XAPC 4, and XAPC 5) were constructed by
ligating clones 6A, 40.2, and 111 via their EcoRI restrictions sites. All frag-
ments were modified at their 5
 
9
 
 end to introduce a start codon contained
in an NcoI site and NH
 
2
 
-terminally linked to six myc-epitope tags in the
vector pCS2
 
1
 
MT (45, 53), which was used for in vitro transcription.
The full-length human APC (hAPC) cDNA and the cDNA fragments
hAPC 21 and hAPC 25, all having an altered 5
 
9
 
 end containing a start
codon in the NcoI restriction site, were isolated out of a baculovirus trans-
fer vector (42) with the appropriate restriction enzymes and inserted into
the vectors pCS2
 
1
 
 or alternatively into pCS2
 
1
 
MT, for which the APC
fragments were linked 5
 
9
 
 with a myc-epitope tag.
 
Immunoprecipitations and Western Blotting
 
Expression of endogenous 
 
Xenopus
 
 APC and its association with 
 
b
 
-cate-
nin and cadherins were analyzed by immunoprecipitation and Western
blotting. About 10 embryos were lysed in 250 
 
m
 
l NP-40 lysis buffer (0.5%
NP-40, 150 mM NaCl, 2 mM EDTA, 10 mM Hepes-NaOH, pH 7.4, 0.02%
NaN
 
3
 
) and centrifuged for 10 min, and the supernatant was incubated ei-
ther for 3 h with anti–
 
b
 
-catenin pAb (serum, diluted 1:500) or overnight
with anti-APC3 pAb (serum, diluted 1:250). Immunocomplexes were pre-
cipitated for 1 h with protein A–Sepharose, washed five times with NP-40
lysis buffer, and eluted in SDS sample buffer. For the detection of APC,
samples were separated on 3% agarose gels that were transferred to nitro-
cellulose by capillary blotting as described (47). Blots were blocked in
PBS supplemented with 5% dry milk and 0.2% Triton X-100 and incu-
bated in the same buffer overnight at 4
 
8
 
C with anti-APC3 pAb (diluted
1:5,000) followed by HRP-conjugated anti–rabbit IgG (Bio Rad Labora-
tories, Melville, NY; diluted 1:3,000) for detection of 
 
Xenopus
 
 APC pro-
teins. Blots were washed and developed with enhanced chemilumines-
cence (Amersham Corp., Arlington Heights, IL). For the detection of
 
b
 
-catenin and cadherins, samples were loaded on 7% SDS polyacrylamide
gel, separated, and blotted to nitrocellulose. For detection of 
 
b
 
-catenin,
blots were incubated for 1 h with anti–
 
b
 
-catenin pAb (serum, diluted 1:
5,000) followed by HRP-conjugated anti–rabbit IgG (Bio Rad Laborato-
ries; diluted 1:3,000). Cadherins were detected either with a mixture of
C-cadherin–specific mAbs 6B6 and 5G5 (hybridoma supernatant, 1:3 di-
luted) or with a mixture of E-cadherin–specific mAbs 19A2 and 5D3 (hy-
bridoma supernatant, 1:3 diluted), followed by HRP-conjugated anti–
mouse IgG (Bio Rad Laboratories; diluted 1:3,000).
Expression of exogenous APC fragments was also analyzed by Western
blotting. Typically, 5–10 embryos were lysed in 250 
 
m
 
l NP-40 lysis buffer.
Lysates were supplemented with an equal volume of 2 
 
3
 
 SDS sample
buffer for analysis of total lysates. Samples were loaded on 3% agarose
gels, separated, and immunoblotted as described above. Blots were incu-
bated for 1 h at room temperature with anti–myc tag mAb 9E10 (5) (as-
cites, diluted 1:1,000) followed by HRP-conjugated anti–mouse IgG (Bio
Rad Laboratories; diluted 1:3,000) for detection of myc-tagged APC pro-
teins.
 
Reverse Transcriptase–PCR Assay
 
Reverse transcriptase (RT)–PCR was performed as described (3, 45).
Typically two embryos or four animal caps were homogenized in 100 
 
m
 
l ly-
sis buffer (0.5% SDS, 5 mM EDTA, 50 mM NaCl, and 50 mM Tris, pH
7.5) containing 250 
 
m
 
g/ml proteinase K (Boehringer Mannheim Biochem-
icals), incubated 30 min at 45
 
8
 
C, and extracted with phenol/chloroform.
After the addition of 10 
 
m
 
g clean yeast tRNA as carrier, nucleic acids were 
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precipitated with 1 M NH
 
4
 
OAc and EtOH. DNA was removed from the
samples by RNase-free DNase (Boehringer Mannheim Biochemicals) at a
concentration of 2 U/25 ml in DNase buffer (10 mM NaCl, 6 mM MgCl
 
2
 
,
100 mM CaCl
 
2
 
, 40 mM Tris, pH 7.9) containing 1 mM DTT and 15 U RNasin
(Promega). After a phenol/chloroform extraction, RNA was precipitated
with NH
 
4
 
OAc and EtOH. Half of the RNA samples were then denatured
at 65
 
8
 
C, and hybridized with random hexamers (Boehringer Mannheim
Biochemicals), and cDNA was made using the Superscript Pream-
plification System (GIBCO BRL, Gaithersburg, MD). A 20-
 
m
 
l reaction
mixture consisted of 1
 
3
 
 first strand buffer (GIBCO BRL), a dNTP mix of
500 mM of each nucleotide, 100 mM DTT, 15 U RNasin (Promega), and
25 U RT (GIBCO BRL). Reactions were incubated for 30 min at 42
 
8
 
C.
One fifth of the cDNA samples was then used for PCR amplification using
either primers for the Siamois cDNA or the ubiquitous expressed elonga-
tion factor 1 (EF-1) cDNA, using a hot start of 93
 
8
 
C for 2.5 min and 25 cy-
cles of 938C for 30 s, 558C for 1 min, and 728C for 30 s. The reaction was
terminated with an incubation of 5 min at 728C. A 25-ml reaction consisted
of 1 3 PCR buffer with Mg21 (Boehringer Mannheim Biochemicals),
dNTPs at 1 mM each, 1 mCi of [32P]dCTP (Amersham Corp.), and 1.25 U
of Taq DNA polymerase (Boehringer Mannheim Biochemicals). The sense
and antisense primers for Siamois detection were TTGTCTCTACCG-
CACTGA and TCCTGTTGACTGCAGACT, respectively, which should
generate a 307-bp fragment. However, we always obtained a double band,
the higher of which was always proportional to the 307-bp band. The
sense and antisense primers for EF-1 detection were CAGATTGGT-
GCTGGATATGC and ACTGCCTTGATGACTCCTAG, respectively,
generating a 268-bp fragment. PCR samples were separated on a 5% acryl-
amide gel and run in 0.5 3 Tris borate EDTA buffer, and PCR fragments
were visualized by autoradiography.
RNA and Protein Injections
All APC constructs were linearized and capped RNAs were synthesized
in vitro using SP6 RNA polymerase (Promega). mRNAs were dissolved in
diethyl pyrocarbonate-treated water at a concentration of 0.125–0.5 ng/nl
and injected in a volume of z15 nl into the equatorial region of a single
prospective ventral (or two dorsal) blastomere of a four-cell stage embryo.
During injection, embryos were kept in a solution of 1 3 Marc’s Modified
Ringer solution (MMR; 100 mM NaCl, 2 mM KCl, 5 mM Hepes-NaOH, pH
7.8, 2 mM CaCl2, and 1 mM MgSO4) supplemented with 6% ficoll to im-
prove healing, 100 U/ml penicillin, and 100 mg/ml streptomycin. After in-
jection, embryos were further incubated in 0.1 3 MMR supplemented
with antibiotics and scored at stage 16–18 for duplicated axis, visible by
the presence of two darkly pigmented neural folds. Staging was according
to Nieuwkoop and Faber (31).
Recombinant APC proteins, eluted in a buffer containing 20 mM Tris,
pH 8.0, 1 mM EDTA, 150 mM NaCl, 1 mM DTT, 10 mg/ml pepstatin, 10
mg/ml leupeptin, 0.5 mM Pefabloc, and 1 mM aprotinin, were concentrated
to 2–4 mg/ml (except for APC 22 for which the final concentration was 0.2
mg/ml) using amicon filters, and then injected as described above for the
synthetic mRNA.
Results
Xenopus APC Is Expressed in Early Embryos and Is 
Associated with b-Catenin But Not with Cadherins
To determine whether APC is expressed in early Xenopus
embryos, the APC protein was detected by immunopre-
cipitation of samples of unfertilized eggs and early em-
bryos at different developmental stages. Immunocomplexes,
separated on a polyacrylamide gel, were immunoblotted
with anti–APC 3 antibodies, revealing a 300-kD band at all
stages analyzed (Fig. 1 A). Signals for endogenous APC
were increased at least twofold when the embryos were
lysed in buffer containing deoxycholate (data not shown).
To determine whether Xenopus APC interacts with b-cate-
nin or cadherins, samples from stage 11 embryos were im-
munoprecipitated with either anti–APC 3 or anti–b-cate-
nin antibodies, and subsequently immunoblotted with
either anti–APC 3, anti–b-catenin, anti–E-cadherin, or anti–
C-cadherin antibodies. APC coimmunoprecipitated with
b-catenin (Fig. 1 B). However, although cadherins coim-
munoprecipitated with b-catenin, they did not coimmuno-
precipitate with APC (Fig. 1 B). Therefore, in early em-
bryos, Xenopus APC is apparently complexed with b-catenin
but not with cadherins, just as it is in mammalian cell lines
(16, 43).
Cloning of Xenopus APC cDNA
We cloned and sequenced APC from a stage 17 Xenopus
gt-10 l cDNA library. The Xenopus APC cDNA encoded
a protein with an estimated molecular mass of 311 kD that
showed 75% sequence similarity with its human counter-
part. High sequence conservation was observed in the cur-
rently described structural motifs, including the oligomer-
ization domain (85% similarity), the armadillo repeats
(97%), the 15-aa repeats (80 and 100%), and the 20-aa re-
peats (90–100%) (Fig. 2). Only two of the three 15-aa re-
Figure 1. Xenopus APC is
expressed throughout early
embryogenesis and is associ-
ated with b-catenin but not
with cadherins. (A) Immuno-
precipitation and immuno-
blotting of endogenous Xe-
nopus APC protein by anti–
APC 3 antibodies. Xenopus
APC is present in the egg
and at least until neurula
stage. (B) Interaction of
APC with b-catenin but not
with cadherins. Stage 11 em-
bryos were lysed in NP-40
buffer and immunoprecipi-
tated (IP) with either APC 3
or b-catenin antibodies. Im-
munocomplexes were blot-
ted (Blot) for either APC,
b-catenin, E-cadherin, or
C-cadherin.The Journal of Cell Biology, Volume 136, 1997 414
peats found in human APC, which were first identified as
the b-catenin binding sites, are present. In these, the con-
sensus sequence EX(D/E)XPXNYSX(K/R)YX(D/E)E was
conserved (51). All seven 20-aa repeats found in human
APC, which can also mediate b-catenin binding, were con-
served and showed the (E/D)XXPXX(F/Y)S consensus
sequence (43). The basic domain was less conserved (67%).
The COOH-terminal 15 aa, which have recently been
shown to interact with the human homologue of the
Drosophila Dlg tumor suppressor protein (23), were 100%
conserved. We conclude that we have indeed cloned the
Xenopus homologue of the human APC tumor suppressor
gene.
Full-Length Xenopus APC Induces a Secondary 
Dorsoanterior Axis
For expression experiments, the partial Xenopus APC
cDNA clones were subcloned separately or linked to-
gether to form a cDNA encoding the entire open reading
frame (Fig. 3 A). To validate the expression in embryos,
full-length XAPC and all partial constructs had an NH2-
terminal myc tag. Synthetic mRNA was injected into four-
cell stage embryos. All fragments were very well expressed
as analyzed by immunoblotting with antibodies against the
myc-epitope tag (Fig. 3 B; not shown for XAPC 5). The
lower molecular weight bands detected during expression
of full-length XAPC FL seem to be degradation products
generated during sample preparation, because extraction
of endogenous Xenopus APC from embryos always results
in similar prominent bands of lower molecular weight
when blotted with anti–APC 3 antibodies (data not shown).
Thus, the exogenous APC mRNA is expressed and its
product behaves like endogenous APC.
Figure 2. Comparison of Xenopus and human APC sequences.
Linear representation of the amino acid sequence similarities be-
tween human and Xenopus APC. Numbers indicate the similarity
of the sequences that were aligned by the Clustal method (PAM
matrix 250, MegAlign; DNASTAR, Inc., Madison, WI). The de-
scribed structural domains including the oligomerization domain
(oligom.), armadillo repeats (arm. repeats), 15-aa repeats, 20-aa
repeats, basic domain, and Dlg binding site are shown. Numbers
beneath the sequences indicate the sequence similarity of the
whole protein, or of the NH2-terminal 1,000 amino acids, the mid-
dle 1,000 amino acids, and the COOH-terminal 850 amino acids,
respectively. The Xenopus APC sequence data are available from
EMBL/GenBank/DDBJ under accession number U64442.
Figure 3. Full-length Xeno-
pus APC or fragments con-
taining the central domain
induce an ectopic dorsoante-
rior axis. (A) Linear repre-
sentation of the full-length
Xenopus APC (xAPC FL)
and the various fragments
used (xAPC 1, 4, and 5). The
amino acid positions of each
fragment are indicated by the
flanking numbers. The mo-
tifs, identified in the human
APC and conserved in the
Xenopus APC cDNA, are
shown on top, including the
oligomerization domain (oli-
gom.), armadillo repeats
(arm. repeats), 15- and 20-aa
repeats, basic domain, and
Dlg binding site. (B) Expres-
sion levels of APC fragments
resulting from the injection
of mRNA of XAPC 1,
XAPC 4, and XAPC FL, re-
spectively. Expression was
detected by immunoblotting
using the anti–myc tag mAb.
(C) Bar graph summarizing
the frequency of axis induc-
tion by the different Xenopus
APC fragments, expressed from injected synthetic mRNA in four-cell stage embryos. Secondary axis formation is plotted as a percent-
age, and the total number of embryos analyzed is indicated to the right of each bar (n).Vleminckx et al. Signaling Activity for Adenomatous Polyposis Coli in Xenopus 415
Injection of XAPC FL mRNA into the ventral side of
four-cell embryos very efficiently induced the formation of
secondary dorsoanterior axes (Fig. 3 C). This often re-
sulted in the generation of Siamese twins connected by
trunk and tail. The phenotype was most clear at the neu-
rula stage (stage 14–15) when the nascent neural tubes are
visible as darkly pigmented lines. Accordingly, this stage
was used for scoring the frequency of axis duplication.
Axis induction occurred .90% of the time with 5–10 ng of
XAPC FL mRNA (Fig. 3 C) and resulted in the develop-
ment of double-headed tadpoles. Ectopic dorsal axes were
also induced by expression of the fragments XAPC 4 and,
even more efficiently, XAPC 5. These findings indicate
that APC is able to induce an ectopic dorsoanterior axis,
and consequently has signal transduction activity. More-
over, the central part of the APC is the minimal require-
ment for axis induction.
The NH2-terminal fragment XAPC 1, which is similar to
a truncated human APC molecule frequently found in co-
lon cancer, caused only a very low background of second-
ary axis induction (6%), and, when observed, the extra
axes were always very short and incomplete. The trun-
cated XAPC 1 fragment still contains a b-catenin binding
site and actually binds b-catenin much more efficiently
than the central part of the APC protein that is required
and sufficient for axis induction (data not shown). This ex-
cludes a model in which axis induction by APC results
from simply binding up b-catenin.
Expression of the NH2-terminal b-catenin binding Xe-
nopus APC fragment in the future dorsal side of a four-
cell stage embryo did not interfere with the formation of
the endogenous dorsal axis (data not shown), and there-
fore this fragment does not inhibit signal transduction pro-
cesses involved in axis determination. Furthermore, NH2-
terminal APC fragments that lack the central domain were
unable to antagonize the axis-inducing APC fragments
when coinjected (data not shown), indicating that they
have no dominant-negative properties.
The Central Domain of Human APC Also Has 
Signaling Activity
Since human APC has been well characterized in terms of
the domains participating in various molecular interac-
tions and truncations associated with colon carcinogenesis,
we also injected human APC fragments, either as recombi-
nant protein or as synthetic mRNA (Fig. 4, A and B). Un-
fortunately, we were unable to get efficient expression of
the full-length human APC (Fig. 4 D). However, frag-
ments representing the central part of the molecule in-
duced an ectopic dorsoanterior axis very efficiently. 80–90%
of the embryos injected with hAPC 2 or hAPC 25 in the
ventral site showed a second axis (Fig. 4 B), many of which
had complete new head structures, including a cement
gland and pigmented eyes (Fig. 4 C). Formation of a weak
partial secondary axis was observed in only 7% of the em-
Figure 4. Human APC frag-
ments induce an ectopic dor-
soanterior axis in early Xeno-
pus embryos. (A) Linear
representation of the full-
length human APC (hAPC
FL) and the various frag-
ments used (hAPC 2, 3, 21,
22, and 25). The amino acid
positions of each fragment
are indicated by the flanking
numbers. Several known mo-
tifs are shown on top, includ-
ing the oligomerization do-
main (oligom.), armadillo
repeats (arm. repeats), the
15- and 20-aa repeats (both
known to bind b-catenin),
basic domain, and Dlg bind-
ing site. (B) Bar graph sum-
marizing the frequency of
axis induction by the differ-
ent APC fragments, either
injected as recombinant pro-
tein (upper) or expressed
from synthetic mRNA
(lower) in four-cell stage em-
bryos. Secondary axis forma-
tion is plotted as a percent-
age, and the total number of embryos (n) analyzed is indicated to the right of each bar. (C) Micrographs showing the double axis
phenotype in embryos injected with recombinant hAPC 2 protein. Embryos are shown at stage 14 (neurula stage), where the forming
neural tubes are visible as darkly pigmented lines, and at the tadpole stage, showing embryos with two complete heads, including two
eye pairs. (D) Expression levels of APC fragments resulting from the injection of mRNA for hAPC 25, hAPC 21, and hAPC FL, respec-
tively. APC fragments were detected by immunoblots using the anti–myc tag mAb.The Journal of Cell Biology, Volume 136, 1997 416
bryos injected with mRNA encoding the NH2-terminal
fragment hAPC 21, and the few embryos scored as posi-
tive had only very short and incomplete secondary axes. A
COOH-terminal fragment hAPC3 was also unable to in-
duce an ectopic dorsoanterior axis. Therefore, similar to
the results with Xenopus APC, the central domain of the
human APC protein has signal transduction activity in the
early Xenopus embryo. Fragments that lack the central
domain, like the NH2-terminal hAPC 21, which corre-
sponds to a mutant APC frequently observed in colon can-
cer, do not show this signal transduction activity.
APC Induces the Expression of a Marker of the 
Nieuwkoop Center, the Homeobox Gene Siamois
Dorsoanterior axis induction by APC is very similar to the
phenotype observed for b-catenin mRNA injections, and
therefore they may act at a similar site in the embryo. b-Cate-
nin participates in the early signaling events in a region
called the Nieuwkoop center (11). Activation of the Nieuw-
koop center by b-catenin and Wnt growth factors induces
the expression of the homeobox protein Siamois, which it-
self causes axis duplication when injected in the ventral
side of an embryo (22). b-Catenin signaling activity seems
to directly induce Siamois (Nelson, R., personal communi-
cation). Induction of Siamois is selective, however, be-
cause it is not induced by other factors that induce mark-
ers of a later signaling center, the Spemann organizer, such
as noggin, activin, and Vg-1 (7). To determine whether
APC, like b-catenin and Wnt, can act in the Nieuwkoop
center, we determined whether ectopic expression of Xe-
nopus APC or human APC could induce Siamois expres-
sion. APC fragments were injected into the animal pole of
four-cell stage embryos. At stage 8, animal caps were dis-
sected and cultured as explants to remove the endogenous
Nieuwkoop center in which Siamois is normally expressed.
Expression of Siamois in animal caps was assayed by RT-
PCR. Full-length Xenopus APC clearly induced Siamois
expression (Fig. 5 A). In contrast, the XAPC 1 fragment,
which corresponds to a truncated APC mutant that has no
major axis-inducing activity, did not induce Siamois ex-
pression. Injection of the human hAPC 25 mRNA also in-
duced Siamois expression in the animal caps in a dose-
dependent manner (Fig. 5 B). Therefore, like b-catenin and
Wnt, the axis-inducing APC fragments mimic the Nieuw-
koop center in the early embryo, suggesting that APC and
b-catenin act in the same signaling pathway.
Role of b-Catenin in Axis Induction by APC
To determine whether induction of a secondary axis by
APC actually depends on b-catenin, we used overexpres-
sion of C-cadherin as a competitive inhibitor. C-Cadherin
is the major cadherin expressed in the early embryo, and it
binds b-catenin with high affinity. Overexpression of C-cad-
herin in early embryos depletes the blastomeres of free,
non–membrane-bound b-catenin and inhibits its signaling
activity (6). C-Cadherin overexpression in oocytes or in
the dorsal vegetal region of embryos results in completely
ventralized embryos (6, 13), and, when coexpressed with
b-catenin, C-cadherin strongly antagonizes the induction
of a secondary axis (6). Therefore, to test the requirement
of b-catenin for APC signaling, we injected 4 ng of hAPC
25 or XAPC FL mRNA either alone or in the presence of
2–5 ng of C-cadherin mRNA. Coexpression of C-cadherin
completely abolished axis duplication by hAPC 25 and
XAPC FL mRNA (Fig. 6). Therefore, free cytosolic b-cate-
nin seems to be required for hAPC 25 and XAPC FL to in-
duce axis duplication. The simplest interpretation of this
epistasis experiment is either that APC and b-catenin act
together as a complex or that b-catenin acts downstream
of APC. However, a more complex model in which b-cate-
nin influences the active state of APC cannot be ruled out.
Levels of b-Catenin Are Not Influenced by 
Overexpressed APC
Certain colon cell lines that express mutant APC contain
high levels of b-catenin. Transfection of these cell lines
with full-length human APC, or fragments containing the
Figure 5. APC induces the
expression of the Hox gene,
Siamois. (A) Siamois expres-
sion is induced only by APC
fragments with axis-inducing
activity. RNA was extracted
from animal caps injected
with synthetic RNA encod-
ing either Xenopus full-
length APC (XAPC FL) or
the NH2-terminal third of the
APC cDNA (XAPC 1) and
analyzed for Siamois expres-
sion by RT-PCR. The ubiqui-
tously expressed elongation
factor 1 (EF-1) was also in-
cluded as a loading control.
As a positive control, RT-
PCR reactions from whole
embryos were loaded. To rule out the possible contamination of genomic DNA, a sample that was not treated with reverse transcriptase
was included (2RT). (B) RT-PCR analysis of the expression of Siamois in animal caps injected with increasing amounts of synthetic
RNA encoding human hAPC 25 mRNA. Whole embryo and uninjected animal caps were loaded as positive and negative controls, re-
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central 20-aa repeats, significantly reduces total b-catenin
levels (29). From these results it has been proposed that
APC is able to increase the turnover of b-catenin, thereby
regulating its cytoplasmic levels and its availability to in-
teract with other proteins. Interestingly, the same or simi-
lar APC fragments that reduce b-catenin levels in these
colon cancer cell lines are able to induce an ectopic dorsal
body axis in Xenopus. This seems contradictory, since ec-
topic APC expression causes a phenotype resembling the
one caused by overexpressed b-catenin rather than re-
duced levels of b-catenin. Therefore, we asked whether
full-length Xenopus XAPC and the active human hAPC
25 fragment were able to influence b-catenin levels in
early  Xenopus embryos.
To achieve uniform expression of exogenous APC, APC
mRNA was injected into the animal pole of all four blas-
tomeres of the four-cell embryo, and animal caps were ex-
planted at stage 8. Expression levels of b-catenin in these
animal caps were determined by immunoblotting. For a
loading control, C-cadherin was also detected. As shown
in Fig. 7 A, b-catenin levels were largely unchanged in the
animal caps expressing XAPC FL. Similarly, no changes in
b-catenin levels were observed after expression of the
axis-inducing human APC fragment hAPC 25 (Fig. 7 A).
We also examined the effects of APC expression on exog-
enously expressed b-catenin, to be sure that the levels of
b-catenin were being measured in the same cells that ex-
pressed exogenous APC. Myc-tagged b-catenin mRNA was
coinjected with the full-length Xenopus APC mRNA or
with hAPC 25 mRNA, and embryos were lysed after 2.5 h
(stage 7) or 4 h (stage 9). The levels of exogenously ex-
pressed b-catenin were determined by immunoblotting us-
ing anti-myc antibodies. As shown in Fig. 7 B, expression
levels of b-catenin were not significantly influenced by
XAPC FL or by hAPC 25. Apparently, the dorsoanterior
axis induction by APC is not associated with any major
changes in expression levels of the endogenous b-catenin. 
It is formally possible that APC acts through regulating
the levels of plakoglobin, a protein that is very similar to
b-catenin. Like b-catenin, plakoglobin is found to associ-
ate with both cadherins and APC and is also able to induce
an ectopic dorsoanterior axis in Xenopus (19). Therefore,
we examined endogenous plakoglobin levels in animal
caps injected with XAPC FL mRNA. No differences be-
tween the levels of plakoglobin in uninjected or XAPC
FL–expressing animal caps were observed (data not shown).
Thus, it is unlikely that dorsoanterior axis induction by
APC is mediated by changes in plakoglobin levels.
Discussion
Our findings implicate the APC tumor suppressor gene in
the process of axial patterning in Xenopus. Since induction
of the dorsoanterior axis involves the activities of embry-
onic signaling centers (or organizers), these findings dem-
onstrate that APC has signal transduction activity. APC
seems to act in the same signaling pathway as b-catenin.
They have similar characteristics, including induction of
the homeobox protein Siamois. Furthermore, APC signal-
ing is strongly dependent on the availability of a free cyto-
solic pool of b-catenin, which by itself has axis-inducing
activity. Moreover, APC or APC/b-catenin complexes
seem to have direct positive signaling activity, since APC
does not act indirectly simply by binding up b-catenin or
by changing the levels of b-catenin. We propose, there-
fore, that axis induction by APC is due to its role in a sig-
nal transduction process in which b-catenin has been
strongly implicated.
The induction of a dorsoanterior axis in Xenopus results
Figure 6. The induction of an ectopic dorsal axis by APC re-
quires free cytosolic b-catenin. APC signaling is inhibited by
coinjected C-cadherin, which sequesters b-catenin at the mem-
brane. Bar graph summarizing the frequency of axis induction of
embryos injected at the four-cell stage at their ventral site with
4 ng of hAPC 25 and XAPC FL mRNA, injected either alone or
in combination with 2 ng of C-cadherin mRNA.
Figure 7. Overexpression of APC in Xenopus does not cause ma-
jor changes in levels of b-catenin. (A) Levels of endogenous b-cat-
enin in animal caps that were isolated from embryos injected four
times in their animal pole with either hAPC 25 or XAPC FL. b-Cat-
enin expression was detected by immunoblotting. For a loading
control, samples were blotted for C-cadherin. (B) Expression lev-
els of myc-tagged b-catenin from exogenous mRNA in stage 7
and stage 9 embryos that were injected earlier at four-4-cell stage
either with 1 ng of myc-tagged b-catenin mRNA alone or in com-
bination with 4 ng of hAPC 25 or XAPC FL mRNA.The Journal of Cell Biology, Volume 136, 1997 418
from localized signaling activity in the early embryo. After
fertilization of the egg, an early dorsalizing zone, called
the Nieuwkoop center, becomes localized and activated in
a vegetal region of the embryo. Later in development, af-
ter the onset of transcription, the Nieuwkoop center in-
duces overlying mesoderm to form a second dorsalizing
center, called the Spemann organizer. In the last decade,
several factors have been identified that can mimic or in-
hibit either of the two dorsalizing centers. These factors in-
clude secreted signaling molecules, cytoplasmic factors
that act as signal transducers, and transcription factors.
Frequently, these different factors are components of a
unique signaling pathway; e.g., Wnt, Dsh, Gsk-3, and b-cate-
nin are all part of the Wnt pathway. Here we demonstrate
that APC is able to mimic a dorsalizing center, probably
the Nieuwkoop center, suggesting that it also has signal
transducing activity.
Comparison of the axis-inducing activities of the differ-
ent Xenopus and human APC fragments indicates that the
central domain of the APC protein is both sufficient and
essential for ectopic axis induction. Truncated APC mu-
tants that lack this central domain of the protein are inef-
fective in dorsoanterior axis induction, indicating that they
lack the signaling activity. The central domain of APC is
missing in the majority of the truncating APC mutations
expressed in tumors from FAP patients and in spontane-
ous colon tumors, suggesting that some growth-suppres-
sive or growth-regulatory activity is present in this region
(39). We hypothesize that the loss of growth-regulatory ac-
tivity results from the loss of the signaling activity present
in the central part of APC.
Polyp formation in the colon occurs after a loss of het-
erozygosity or a mutation of the remaining APC allele, in-
dicating that the truncated APC mutants are not domi-
nant-negative proteins (34, 35). Consistent with the data
from colon carcinogenesis, the COOH-terminally trun-
cated APC mutants have no dominant-negative properties
in the Xenopus embryo, since they cannot interfere with
the formation of the endogenous dorsal axis and cannot
antagonize the effects of axis-inducing APC fragments
when coinjected (data not shown).
The cellular function of the APC protein was a complete
mystery until the discovery that it binds catenins, proteins
associated with cadherin adhesion molecules. The associa-
tion of APC with catenins initially led to the proposal that
APC has a role in regulating the activity of the catenin/
cadherin complex and thus intercellular adhesion (14, 42,
51). This seemed to have implications for colon carcino-
genesis because changes in cell adhesion could affect pro-
cesses like cell migration and shedding, which could be im-
portant for the development of colon polyps. Also, it has
been proposed that APC is involved in cell migration (30).
However, the discovery that b-catenin and plakoglobin
have signal transducing activity in Xenopus embryos (8,
13, 19), independent of their role in cell adhesion, raised
the possibility that the observed APC/catenin association
reflects a role for APC in signal transduction. Although a
role for APC in cell adhesion cannot be ruled out, our data
demonstrate that the cellular function of APC is certainly
not limited to the regulation of the adhesiveness and mi-
gration of cells. Axis induction in Xenopus by APC is iden-
tical to the phenotype resulting from overexpressed b-cate-
nin, and therefore involves a related signal transduction
activity.
APC may be involved in a Wnt-like signaling pathway.
Ectopically expressed b-catenin is known to mimic the
Nieuwkoop center (11). Similarly, APC induces expres-
sion of Siamois, a marker for this Nieuwkoop center (22).
This signaling activity is shared by several components of
the Wnt signaling pathway, including Wnts themselves and
a kinase-mutant form of GSK-3. Our findings suggest that
APC and b-catenin act at the same place in this signaling
pathway. Not only do they form complexes in the early
Xenopus embryo, but axis induction by APC also depends
on the availability of free cytosolic b-catenin. Overexpres-
sion of C-cadherin, which sequesters the cytosolic b-cate-
nin to the membrane, strongly inhibits axis induction by
APC. In fact, C-cadherin injection can inhibit axis forma-
tion induced by the different components of the Wnt/Wg
signaling pathway that act upstream of b-catenin, like
XWnt 8 and kinase-defective GSK-3, but it is not able to
suppress axis formation by factors that act independently
from the Wnt signaling pathway (e.g., Vg-1, activin, and
noggin) or that act downstream of b-catenin (e.g., Siam-
ois) (7). The inhibition of APC signaling by depletion of
cytosolic b-catenin suggests that APC acts either upstream
of b-catenin or that APC and b-catenin act together as a
complex.
Our findings do not directly address whether APC is a
component of a Wnt pathway rather than, for example, an
independent or parallel regulator of b-catenin. However,
there are biochemical data showing that APC can physi-
cally interact with another component of the Wnt/Wg
pathway, GSK-3 (homologue of the Drosophila zw-3)
(44). Moreover, APC seems to be a good substrate for
GSK-3 in vitro. Together, these links of APC to both up-
stream and downstream components of the Wnt pathway
suggest that it is directly involved in the signal transduc-
tion mechanism. Nevertheless, proof that APC is indeed
part of the Wnt/Wg pathway will require a demonstration that
the loss or inhibition of its function blocks Wnt signaling.
APC has been reported to be able to reduce b-catenin
expression levels in certain colon cancer cell lines by en-
hancing its turnover (29). Interestingly, the activation of
the wingless pathway in Drosophila seems to result in in-
creased stability of Armadillo protein (41, 54), and overex-
pression of a kinase-dead GSK-3 in Xenopus also results
in increased stability of b-catenin (56). From this finding,
it has been speculated that APC, through its proposed
ability to regulate the stability of b-catenin, is a negative
regulator in the Wnt/Wg pathway (25, 37). However, in-
creased turnover of b-catenin by APC in the colon cancer
cell lines was not related to any observable cellular func-
tion. Furthermore, induction of apoptosis by APC intro-
duction in other colon cancer cells was not accompanied
by reduction of b-catenin levels (27). Similarly, we find
that the APC signaling activity in early Xenopus embryos,
which is manifested by dorsal axis induction, is apparently
not due to its regulation of b-catenin levels. First, the en-
hanced turnover of b-catenin by APC or the central re-
peats in colon cancer cell lines are inconsistent with our
findings that the very same APC molecules stimulate axis
induction, a process associated with increased levels of
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els of either endogenous b-catenin (or plakoglobin) or
b-catenin expressed from injected mRNA, in response to
expression of either full-length Xenopus APC or the axis-
inducing central fragment of the human APC. Our findings
in Xenopus embryos suggest that APC, or APC/b-catenin
complexes, have signaling activity on their own, indepen-
dent from the regulation of b-catenin levels. It is possible
that the increased turnover of b-catenin by APC, which is
observed in colon cancer cell lines, is part of a different
signaling mechanism, or is the result of a feedback loop
that turns off the signaling by APC and b-catenin. Our re-
sults also suggest that APC is an activating, rather than an
inhibiting, component of the Wnt/Wg pathway. More re-
search is needed to clarify the exact function and activity
of APC in this pathway.
Both overexpressed b-catenin and plakoglobin are known
to localize in the nuclei of injected Xenopus blastomeres
(8, 19). Endogenous b-catenin also has been found in the
nuclei of blastomeres at the dorsal side of both Xenopus
and Zebrafish embryos (46, 56). b-Catenin lacks the classi-
cal nuclear localization sequence needed for nuclear im-
port. However, members of the lymphoid enhancer-1/Tcf
family of transcription factors have recently been identi-
fied as proteins that bind to b-catenin and can, under cer-
tain conditions, carry b-catenin to the nucleus (2, 15, 26).
We have not yet been able to detect major changes in the
subcellular localization of endogenous b-catenin in blas-
tomeres overexpressing ectopic full-length Xenopus APC
(data not shown). This is, however, most likely due to lack
of sensitivity since it was not easy to detect nuclear local-
ization of endogenous b-catenin either in the natural or
Wnt-induced dorsal side of Xenopus embryos (8, 56).
Using axis formation in Xenopus embryogenesis as a
model system to investigate signaling pathways, we have
uncovered a signaling function for APC that might be rele-
vant for understanding its role in colon carcinogenesis.
One role for APC signaling in oncogenesis might be the
regulation of cell proliferation or sensitivity to transforma-
tion. APC has been shown to alter the transformation
properties, decrease the growth rate or induce apoptosis in
colon carcinoma cells (10, 27), and block the cell cycle pro-
gression from G0/G1 to S phase in fibroblasts (1), possibly
by regulating the activity of cyclin-dependent kinase com-
plexes. b-Catenin also has recently been implicated in on-
cogenesis. An NH2-terminally deleted b-catenin was iden-
tified by its transformation potential in a screen for
oncogenes (55). Furthermore, similar to the data from co-
lon cancer cell lines, increased cytosolic and nuclear local-
ization of b-catenin in adenomas and carcinomas of FAP
patients has been reported (17). Our findings raise the
possibility that APC may regulate cell proliferation in the
colon by virtue of its role as a signal transducing protein
that is associated with signaling by b-catenin. It is conceiv-
able that the downstream targets of APC are dependent
on the cell or tissue context. Thus, the same signaling ac-
tivity that regulates dorsoanterior axis formation in Xeno-
pus embryos could suppress or regulate growth in colon
tissue. Lack of this signaling activity in the truncated mu-
tant APC proteins would consequently result in hyperpro-
liferation and polyp formation. Hence, the early Xenopus
embryo might be a powerful system for elucidating mecha-
nisms of signal transduction by APC in general.
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